ACCESS TO INVESTIGATIONAL DRUGS

Here’s where you can learn all about our policies, eligibility guidelines and the process of gaining access.

DISEASE/TREATMENT

The patient has a disease or condition that is “serious” or “immediately life-threatening,” and there’s no comparable or satisfactory alternative treatment available to them. Also, the patient must not be eligible for and must not have access to a current Eisai clinical trial.

DRUG DEVELOPMENT

Providing the investigational drug will not interfere with the initiation, conduct or completion of Eisai’s clinical trials or development of the drug. Also, the drug requested isn’t available in the patient’s country.

RISK/BENEFIT

Eisai determines that the potential benefits of treatment with the investigational drug outweigh the potential risks to the patient. This assessment takes into consideration the condition of the patient and the sufficiency of safety and efficacy data for the investigational drug. The potential risks must be reasonable given the disease or condition to be treated.

LEGAL, REGULATORY AND OTHER REQUIREMENTS

Providing the investigational drug complies with applicable local, legal and regulatory requirements. This includes any necessary reviews and approvals by health authorities and institutional review boards/ethics committees, as well as use of the drug under the supervision of a licensed physician.

YOU’RE ABOUT TO LEAVE US.EISAI.COM

Click CONTINUE and you’ll be taken to the website of our global parent company, Eisai Co., Ltd., Japan site. Want to stay on our U.S. site? Simply click CANCEL.

HERE’S HOW TO TAKE THE NEXT STEP TOWARD GAINING ACCESS

IF YOU’RE A PHYSICIAN AND YOU THINK YOUR PATIENT MAY BE ELIGIBLE:

Please call Eisai Medical Information at 888-274-2378 (Monday - Friday, 8:30 a.m. - 5:00 p.m. Eastern Time) or email us at Esi_medinfo@eisai.com (for Neurology) or Esi_oncmedinfo@eisai.com (for Oncology). We’ll get back to you within two business days to let you know we’ve received your request.

IF YOU’RE A PATIENT:

Please work through your treating physician to see if you’re eligible for access to Eisai’s investigational drugs under an individual or group program.

IF YOU HAVE A PATIENT WHO CAN’T AFFORD A COMMERCIALLY AVAILABLE DRUG: 

Please look into Eisai’s reimbursement resources to see if your patient qualifies for one of our Patient Assistance Programs (PAPs).

Please note that neither this website, nor Eisai’s policies and procedures, are intended to provide, nor should be construed as providing, automatic access to the Company’s products.